Regression of Subcutaneous B16 Melanoma Tumors After Intratumoral Delivery of an IL-15-expressing Plasmid Followed by in Vivo Electroporation
Cancer Gene Therapy - United Kingdom
doi 10.1038/sj.cgt.7700973
Full Text
Open PDFAbstract
Available in full text
Date
June 9, 2006
Authors
Publisher
Springer Nature